DOCSLIB.ORG

The Nucleotide Sequence for a Proline-Activating Domain of Gramicidin S Synthetase 2 Gene from Bacillus Brevis1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Nucleotide Sequence for a Proline-Activating Domain of Gramicidin S Synthetase 2 Gene from Bacillus Brevis1 J. Biochem. 110, 111-119 (1991) The Nucleotide Sequence for a Proline-Activating Domain of Gramicidin S Synthetase 2 Gene from Bacillus brevis1 Kazuko Hori,* Yoshihiro Yamamoto,* * Kazuhiko Tokita,* Fumihiko Saito,* Toshitsugu Kurotsu, * Masayuki Kanda, * Kaori Okamura, * Junichi Furuyama, and Yoshitaka Saito* *Department of Biochemistry and *'Department of Genetics , Hyogo College of Medicine, Mukogawa-cho, Nishinomiya, Hyogo 663 Received for publication, January 24, 1991 A fragment encoding proline-activating domain (grs 2-pro) of gramicidin S synthetase 2 (GS 2) was found in an 8.1-kilobase pairs (kb) DNA fragment of Bacillus brevis Nagano, which contained the full length of GS 1 gene (grs 1). The clones designated GS719 and GS708, which expressed gramicidin S synthetase 1, were elucidated to express immunoreactive proteins to GS 2 antibodies with approximate molecular weights of 115,000, 105,000 (GS719), and 110,000 (GS708). The partial purification of the gene products of these clones was carried out using DEAE-Sepharose CL-6B column chromatography. The immunore active proteins to GS 2 antibodies were separated from gramicidin S synthetase 1 protein and had specific proline-dependent ATP-32PP, exchange activity. The nucleotide sequence for the proline-activating domain in the 8.1-kb insert was determined. This fragment was 2,879 base pairs long, and encoded 959 amino acids. The calculated molecular weight of 111,671 was consistent with the apparent molecular weight of 115,000 found in SDS-PAGE of the immunoreactive products to GS 2 antibodies. The open reading frame for this protein followed grs 1 gene, though two were separated by a 73-base pair noncoding sequence, and remained open to the end. A comparison of the putative amino acid sequence of grs 2-pro gene product showed that the amino-terminal region was highly homologous to the available sequence of tyrocidine synthetase 2 (71% similarity) and the carboxy-terminal region of the gene product had significant homology to the amino-terminal half of GS 1(66% similarity), as well as to other antibiotic peptide synthetases, tyrocidine synthetase 1 and ƒÂ-(L-ƒ¿-aminoadipyl)-L-cysteinyl-D-valine synthetase (ACVS), an enzyme involved in penicillin biosynthesis. A cyclic decapeptide antibiotic, gramicidin S, (D-Phe- and included the full length of GS 1 gene. The sequence L-Pro-L-Val-L-Orn-L-Leu)2, is produced by various strains analysis of GS 1 gene was carried out using pGS309 (7). of Bacillus brevis at the beginning of the stationary phase of Three open reading frames of sufficient length to encode the growth. The synthesis of gramicidin S is catalyzed by protein were present in the 4.6-kb insert. GS 1 gene was the gramicidin S synthetase 1 (GS 1) [EC 5.1.1.11 ] and 2 (GS second open reading frame and the others were incomplete 2), which have molecular weights of 120,000 and 280,000, frames. The other clones, pGS708 and pGS719, contained respectively (1). GS 1 activates, thioesterifies, and race longer inserts (8.1kb) which were the same but inserted in mizes phenylalanine (2) and GS 2, a multifunctional opposite orientations (7). These inserts involved two other polypeptide, activates and thioesterifies other constituent open reading frames of about 1.5 and 3kb long, upstream amino acids (3, 4). Peptide elongation is initiated by the and downstream from the grs 1 gene, respectively. transfer of D-phenylalanine from GS 1 to GS 2 (5), subse Recently Kratzschmar et al. reported the DNA sequence quent peptidyltransfers to 4•L-phosphopantetheine and from of about 5.9 kb of the gramicidin S synthetase gene, the cofactor to the following specific amino acid give rise to including the full length of the GS 1 gene and a new gene a pentapeptide (6), and then two identical peptides cyclize encoding a 29.1-kDa protein of unknown function before GS to form gramicidin S by an unknown mechanism. 1 gene, as well as 732 base pairs of an incomplete open Recently we reported the cloning and sequencing of the reading frame considered to be a part of the GS 2 gene (8). entire GS 1 gene from B. brevis Nagano (7). We have They suggested that these genes are organized in an operon. isolated four clones which expressed GS 1 activity (7). In this paper, we report the nucleotide and deduced Three of these clones, pGS309, pGS708, and pGS719 amino acid sequences of the gene behind the grs 1 gene contained about 4.6-, 8.1-, and 8.1-kb inserts, respectively, using pGS708, pGS719 and show that this gene product is immunoreactive to GS 2 antibodies and has a specific ' This work was supported in part by a research grant from the Hyogo proline-activation activity and a molecular weight of about College of Medicine. 110,000. Abbreviations: SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; IPTG, isopropyl ƒÀ-D-thiogalactoside; p-amidino PMSF, (p-amidinophenyl)methanesulfonyl fluoride. Vol. 110, No. 1, 1991 111 112 K. Hori et al. Sequence analysis was carried out by using the sequence MATERIALS AND METHODS analysis software package DNASIS (Hitachi Software Engineering). Bacterial Strains and Plasmids•\Gramicidin S producer Partial Purification of the Translated Products of B. brevis Nagano and its mutant strains were used as a GS708 and GS719 in Large Scale Preparation-E. coli source of chromosomal DNA. E. coli, JM103(ƒ¢P1) JM103 cells carrying pGS708 or pGS719 were grown at [4(lac-pro); thi, strA, supE, endAsbcB, hsdR, F'traD36, 37•Ž overnight in 5 liters of L-broth supplemented with proAB, lacIq, Zƒ¢M15] or E. coli DH-1 [recA1, endA1, ampicillin (100mg/ml) and IPTG (50ƒÊM). About 15g of gyrA96, thi-1, hsdR17 (rk-, mk-), supE44] were used as cells was harvested and stored at -20•Ž. Translated host cells for recombinant plasmids. products were purified from a lysate of the frozen cell paste The recombinant plasmids pGS309, pGS708, and by the procedure described previously (7). The lysate was pGS719 contained the GS 1 gene on 4.6-, 8.1-, and 8.1-kb fractionated with 50% saturated ammonium sulfate and the inserts in pUC18, respectively (7). dialyzed fraction was subjected to DEAE-Sepharose CL-6B Western Blot Analysis of the Translated Products of the column chromatography (1.5 X 45 cm) with a linear gradi Recombinant Plasmids-E. coli cells transformed by the ent of 0 to 0.28M KCl in buffer A [50mM potassium recombinant plasmids were grown at 37•Ž overnight in phosphate buffer (pH7.5), 1mM dithiothreitol, 1mM L-broth medium supplemented with ampicillin and with or MgCl2, 0.5mM EDTA, 10ƒÊM p-amidino PMSF, 10% without IPTG as described previously (7). Total cellular glycerol]. proteins from lysed cells or the fraction from DEAE- Enzyme Assay-Activities of the amino acid-dependent Sepharose CL-6B column chromatography were subjected ATP -32PP1 exchange reaction were measured as described to SDS-PAGE on 7.5% polyacrylamide gels as described by previously (3). Laemmli (9). Proteins were transferred to a Durapore filter Biochemicals•\[ƒ¿-32P]dCTP and 32PP1 were purchased membrane (Millipore) and the blots were treated with a from the Radiochemical Centre (Amersham, U.K.). Re 1 : 1,000 dilution of anti-GS 1 antibodies or 1:5,000 striction endonucleases were purchased from Takara Shuzo dilution anti-GS 2 antibodies and visualized with horse- (Kyoto) and Nippon Gene (Toyama). DNase and RNase radish peroxidase conjugated anti-rabbit IgG using 3,3•L-di were obtained from Sigma Chemical (St. Louis, U.S.A.). - aminobenzidine (7). The DNA ligase and E. coli alkaline phosphatase were Preparation of the Antibodies against Gramicidin S purchased from Takara Shuzo. All other chemicals were Synthetase 1 and Synthetase 2•\Antiserum against the standard commercial products. purified GS 1 was prepared as described previously (7). Polyclonal antibodies against the purified GS 2 were RESULTS prepared in a similar way to anti GS 1. GS 2 antibodies were further purified by using DEAE-cellulose column Detection of Immunoreactive Proteins to GS 2 Antibodies chromatography. GS 2 used for raising antibodies was in the Translated Products of the Recombinant Plasmids -Figure 1 shows the Western blot analysis of the transla purified from B. brevis as described previously (3) with some modifications. A DEAE-Sepharose CL-6B column ed products from the recombinant plasmids, pGS309, was used instead of a DEAE-cellulose column and this step pGS708, and pGS719. All these plasmids had the full was carried out before the Ornithine-Sepharose 4B column length of GS 1 gene and the sizes of the inserts were 4.6, chromatography. 8.1, and 8.1kb, respectively. DNA Sequence Analysis-DNA sequences were deter- The translated products from pGS309 included GS 1 mined for both strands by the dideoxy-chain termination protein as described previously (7). GS 1 protein was also method of Sanger et al. (10) as described previously (7). detected in the translated products from pGS708 or Fig. 1. Western blot analysis of total cellu lar proteins from E. coli cells transformed by recombinant plasmids. Total cellular proteins present in the supernatant of lysed cells were subjected to SDS-PAGE on 7.5% poly acrylamide gels and proteins were transferred electrophoretically to Durapore membrane and reacted with GS 1 antibodies (A) or GS 2 antibodies (B), and then visualized as described in "MATERIALS AND METHODS." (A) Lane 1, lysate from E. coli JM103ƒ¢P1 containing pUC18; lane 2, purified GS 1 from B. brevis; lanes 3-5, lysate from E. coli JM103ƒ¢P1 containing pGS309, pGS708, and pGS719, respectively. (B) Lane 1, lysate from E. coli JM103ƒ¢P1 containing pUC18; lane 2, purified GS 2 from B.
Load more

Recommended publications
  • Infant Antibiotic Exposure Search EMBASE 1. Exp Antibiotic Agent/ 2
    Infant Antibiotic Exposure Search EMBASE 1. exp antibiotic agent/ 2. (Acedapsone or Alamethicin or Amdinocillin or Amdinocillin Pivoxil or Amikacin or Aminosalicylic Acid or Amoxicillin or Amoxicillin-Potassium Clavulanate Combination or Amphotericin B or Ampicillin or Anisomycin or Antimycin A or Arsphenamine or Aurodox or Azithromycin or Azlocillin or Aztreonam or Bacitracin or Bacteriocins or Bambermycins or beta-Lactams or Bongkrekic Acid or Brefeldin A or Butirosin Sulfate or Calcimycin or Candicidin or Capreomycin or Carbenicillin or Carfecillin or Cefaclor or Cefadroxil or Cefamandole or Cefatrizine or Cefazolin or Cefixime or Cefmenoxime or Cefmetazole or Cefonicid or Cefoperazone or Cefotaxime or Cefotetan or Cefotiam or Cefoxitin or Cefsulodin or Ceftazidime or Ceftizoxime or Ceftriaxone or Cefuroxime or Cephacetrile or Cephalexin or Cephaloglycin or Cephaloridine or Cephalosporins or Cephalothin or Cephamycins or Cephapirin or Cephradine or Chloramphenicol or Chlortetracycline or Ciprofloxacin or Citrinin or Clarithromycin or Clavulanic Acid or Clavulanic Acids or clindamycin or Clofazimine or Cloxacillin or Colistin or Cyclacillin or Cycloserine or Dactinomycin or Dapsone or Daptomycin or Demeclocycline or Diarylquinolines or Dibekacin or Dicloxacillin or Dihydrostreptomycin Sulfate or Diketopiperazines or Distamycins or Doxycycline or Echinomycin or Edeine or Enoxacin or Enviomycin or Erythromycin or Erythromycin Estolate or Erythromycin Ethylsuccinate or Ethambutol or Ethionamide or Filipin or Floxacillin or Fluoroquinolones
    [Show full text]
  • Genes in Eyecare Geneseyedoc 3 W.M
    Genes in Eyecare geneseyedoc 3 W.M. Lyle and T.D. Williams 15 Mar 04 This information has been gathered from several sources; however, the principal source is V. A. McKusick’s Mendelian Inheritance in Man on CD-ROM. Baltimore, Johns Hopkins University Press, 1998. Other sources include McKusick’s, Mendelian Inheritance in Man. Catalogs of Human Genes and Genetic Disorders. Baltimore. Johns Hopkins University Press 1998 (12th edition). http://www.ncbi.nlm.nih.gov/Omim See also S.P.Daiger, L.S. Sullivan, and B.J.F. Rossiter Ret Net http://www.sph.uth.tmc.edu/Retnet disease.htm/. Also E.I. Traboulsi’s, Genetic Diseases of the Eye, New York, Oxford University Press, 1998. And Genetics in Primary Eyecare and Clinical Medicine by M.R. Seashore and R.S.Wappner, Appleton and Lange 1996. M. Ridley’s book Genome published in 2000 by Perennial provides additional information. Ridley estimates that we have 60,000 to 80,000 genes. See also R.M. Henig’s book The Monk in the Garden: The Lost and Found Genius of Gregor Mendel, published by Houghton Mifflin in 2001 which tells about the Father of Genetics. The 3rd edition of F. H. Roy’s book Ocular Syndromes and Systemic Diseases published by Lippincott Williams & Wilkins in 2002 facilitates differential diagnosis. Additional information is provided in D. Pavan-Langston’s Manual of Ocular Diagnosis and Therapy (5th edition) published by Lippincott Williams & Wilkins in 2002. M.A. Foote wrote Basic Human Genetics for Medical Writers in the AMWA Journal 2002;17:7-17. A compilation such as this might suggest that one gene = one disease.
    [Show full text]
  • Multiplex De Novo Sequencing of Peptide Antibiotics
    JOURNAL OF COMPUTATIONAL BIOLOGY Volume 18, Number 11, 2011 Research Articles # Mary Ann Liebert, Inc. Pp. 1371–1381 DOI: 10.1089/cmb.2011.0158 Multiplex De Novo Sequencing of Peptide Antibiotics HOSEIN MOHIMANI,1 WEI-TING LIU,2 YU-LIANG YANG,3 SUSANA P. GAUDEˆ NCIO,4 WILLIAM FENICAL,4 PIETER C. DORRESTEIN,2,3 and PAVEL A. PEVZNER5 ABSTRACT Proliferation of drug-resistant diseases raises the challenge of searching for new, more efficient antibiotics. Currently, some of the most effective antibiotics (i.e., Vancomycin and Daptomycin) are cyclic peptides produced by non-ribosomal biosynthetic pathways. The isolation and sequencing of cyclic peptide antibiotics, unlike the same activity with linear peptides, is time-consuming and error-prone. The dominant technique for sequencing cyclic peptides is nuclear magnetic resonance (NMR)–based and requires large amounts (milli- grams) of purified materials that, for most compounds, are not possible to obtain. Given these facts, there is a need for new tools to sequence cyclic non-ribosomal peptides (NRPs) using picograms of material. Since nearly all cyclic NRPs are produced along with related analogs, we develop a mass spectrometry approach for sequencing all related peptides at once (in contrast to the existing approach that analyzes individual peptides). Our results suggest that instead of attempting to isolate and NMR-sequence the most abundant com- pound, one should acquire spectra of many related compounds and sequence all of them simultaneously using tandem mass spectrometry. We illustrate applications of this approach by sequencing new variants of cyclic peptide antibiotics from Bacillus brevis, as well as sequencing a previously unknown family of cyclic NRPs produced by marine bacteria.
    [Show full text]
  • Teleomorph Hypocrea Jecorina)
    Downloaded from orbit.dtu.dk on: Dec 20, 2017 Unraveling the Secondary Metabolism of the Biotechnological Important Filamentous Fungus Trichoderma reesei ( Teleomorph Hypocrea jecorina) Jørgensen, Mikael Skaanning; Larsen, Thomas Ostenfeld; Mortensen, Uffe Hasbro; Aubert, Dominique Publication date: 2013 Document Version Publisher's PDF, also known as Version of record Link back to DTU Orbit Citation (APA): Jørgensen, M. S., Larsen, T. O., Mortensen, U. H., & Aubert, D. (2013). Unraveling the Secondary Metabolism of the Biotechnological Important Filamentous Fungus Trichoderma reesei ( Teleomorph Hypocrea jecorina). Kgs. Lyngby: Technical University of Denmark (DTU). General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Unraveling the Secondary Metabolism of the Biotechnological Important Filamentous Fungus Trichoderma reesei (Teleomorph Hypocrea jecorina) MJ-T-030 Mikael Skaanning Jørgensen Ph.D. Thesis November 2012 MJ-T-020 MJ-T-032 28 8 20 27 5 28 1 30 17 8 24 25 9 25 31 13 15 26 16 4 24 12 32 18 11 3 14 13 19 10 5 7 2 9 2521 22 23 Unraveling the Secondary Metabolism of the Biotechnological Important Filamentous Fungus Trichoderma reesei (Teleomorph Hypocrea jecorina) Mikael Skaanning Jørgensen Ph.D.
    [Show full text]
  • Adenylation Enzyme Characterization Using Γ -18O4-ATP
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Chemistry & Biology Brief Communication Adenylation Enzyme Characterization 18 Using g - O4-ATP Pyrophosphate Exchange Vanessa V. Phelan,1 Yu Du,1 John A. McLean,1 and Brian O. Bachmann1,* 1Department of Chemistry, Vanderbilt University, Nashville, TN 37204, USA *Correspondence: [email protected] DOI 10.1016/j.chembiol.2009.04.007 SUMMARY ceuticals including penicillin, vancomycin, and rapamycin, to name a few (Fischbach and Walsh, 2006; Sieber and Marahiel, We present here a rapid, highly sensitive nonradioac- 2005). tive assay for adenylation enzyme selectivity determi- The biochemical assay of decoupled synthetases poses prac- nation and characterization. This method measures tical challenges because most adenylation reactions are not the isotopic back exchange of unlabeled pyrophos- formally catalytic. Isolated synthetases perform half-reactions 18 (Figure 1B) for subsequent amino acid (thio)esterification that phate into g- O4-labeled ATP via matrix-assisted laser desorption/ionization time-of-flight mass spec- are nearly stoichiometric with regard to their respective tRNA/T domains and aminoacyl adenylates are tightly bound enzyme trometry (MS), electrospray ionization liquid chroma- intermediates. Conventionally, adenylation enzyme selectivity tography MS, or electrospray ionization liquid chro- has been assayed using the ATP-32PPi (pyrophosphate) isotope matography-tandem MS and is demonstrated for exchange assay. In this method, the synthetase is incubated with both nonribosomal (TycA, ValA) and ribosomal excess 32PPi, amino acid, and ATP, and the reversible back synthetases (TrpRS, LysRS) of known specificity. exchange of labeled 32PPi into ATP is monitored by solid-phase This low-volume (6 ml) method detects as little as capture of ATP on activated charcoal followed by scintillation 0.01% (600 fmol) exchange, comparable in sensitivity counting.
    [Show full text]
  • E3 Appendix 1 (Part 1 of 2): Search Strategy Used in MEDLINE
    This single copy is for your personal, non-commercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution, contact CJHP at [email protected] Appendix 1 (part 1 of 2): Search strategy used in MEDLINE # Searches 1 exp *anti-bacterial agents/ or (antimicrobial* or antibacterial* or antibiotic* or antiinfective* or anti-microbial* or anti-bacterial* or anti-biotic* or anti- infective* or “ß-lactam*” or b-Lactam* or beta-Lactam* or ampicillin* or carbapenem* or cephalosporin* or clindamycin or erythromycin or fluconazole* or methicillin or multidrug or multi-drug or penicillin* or tetracycline* or vancomycin).kf,kw,ti. or (antimicrobial or antibacterial or antiinfective or anti-microbial or anti-bacterial or anti-infective or “ß-lactam*” or b-Lactam* or beta-Lactam* or ampicillin* or carbapenem* or cephalosporin* or c lindamycin or erythromycin or fluconazole* or methicillin or multidrug or multi-drug or penicillin* or tetracycline* or vancomycin).ab. /freq=2 2 alamethicin/ or amdinocillin/ or amdinocillin pivoxil/ or amikacin/ or amoxicillin/ or amphotericin b/ or ampicillin/ or anisomycin/ or antimycin a/ or aurodox/ or azithromycin/ or azlocillin/ or aztreonam/ or bacitracin/ or bacteriocins/ or bambermycins/ or bongkrekic acid/ or brefeldin a/ or butirosin sulfate/ or calcimycin/ or candicidin/ or capreomycin/ or carbenicillin/ or carfecillin/ or cefaclor/ or cefadroxil/ or cefamandole/ or cefatrizine/ or cefazolin/ or cefixime/ or cefmenoxime/ or cefmetazole/ or cefonicid/ or cefoperazone/
    [Show full text]
  • The Inducers 1,3-Diaminopropane and Spermidine Cause The
    JOURNAL OF PROTEOMICS 85 (2013) 129– 159 Available online at www.sciencedirect.com www.elsevier.com/locate/jprot The inducers 1,3-diaminopropane and spermidine cause the reprogramming of metabolism in Penicillium chrysogenum, leading to multiple vesicles and penicillin overproduction Carlos García-Estradaa,⁎, Carlos Barreiroa, Mohammad-Saeid Jamia, Jorge Martín-Gonzáleza, Juan-Francisco Martínb,⁎⁎ aINBIOTEC, Instituto de Biotecnología de León, Avda. Real no. 1, Parque Científico de León, 24006 León, Spain bÁrea de Microbiología, Departamento de Biología Molecular, Universidad de León, Campus de Vegazana s/n; 24071 León, Spain ARTICLE INFO ABSTRACT Article history: In this article we studied the differential protein abundance of Penicillium chrysogenum in Received 21 February 2013 response to either 1,3-diaminopropane (1,3-DAP) or spermidine, which behave as inducers Accepted 15 April 2013 of the penicillin production process. Proteins were resolved in 2-DE gels and identified by Available online 30 April 2013 tandem MS spectrometry. Both inducers produced largely identical changes in the proteome, suggesting that they may be interconverted and act by the same mechanism. Keywords: The addition of either 1,3-DAP or spermidine led to the overrepresentation of the last 1,3-diaminopropane enzyme of the penicillin pathway, isopenicillin N acyltransferase (IAT). A modified form of Spermidine the IAT protein was newly detected in the polyamine-supplemented cultures. Both Penicillin inducers produced a rearrangement of the proteome resulting in an overrepresentation of Penicillium chrysogenum enzymes involved in the biosynthesis of valine and other precursors (e.g. coenzyme A) of Vesicles penicillin. Interestingly, two enzymes of the homogentisate pathway involved in the degradation of phenylacetic acid (a well-known precursor of benzylpenicillin) were reduced following the addition of either of these two inducers, allowing an increase of the phenylacetic acid availability.
    [Show full text]
  • Structural Basis for the Activation of Phenylalanine in the Non-Ribosomal Biosynthesis of Gramicidin S
    The EMBO Journal Vol.16 No.14 pp.4174–4183, 1997 Structural basis for the activation of phenylalanine in the non-ribosomal biosynthesis of gramicidin S Elena Conti1,2, Torsten Stachelhaus3, the peptide product. Each amino acid is activated by Mohamed A.Marahiel3 and Peter Brick1,4 adenylation of its carboxylate group with ATP and then transferred to the thiol group of an enzyme-bound phospho- 1Biophysics Section, Blackett Laboratory, Imperial College, pantetheine cofactor for possible modification and the 3 London SW7 2BZ, UK and Biochemie/Fachbereich Chemie, elongation reaction (Stachelhaus and Marahiel, 1995a; Philipps-Universita¨t Marburg, D-35032 Marburg, Germany Kleinkauf and von Do¨hren, 1996). 2 Present address: Laboratory of Molecular Biophysics, The cloning and sequencing of several peptide synthe- Rockefeller University, New York, NY10021, USA tase genes have revealed a conserved and ordered modular 4Corresponding author organization. Each module encodes a functional building unit containing ~1000 amino acids, which specifically The non-ribosomal synthesis of the cyclic peptide recognizes a single amino acid. Within such a protein antibiotic gramicidin S is accomplished by two large template-directed peptide biosynthesis, the occurrence and multifunctional enzymes, the peptide synthetases 1 and specific order of the modules in the genomic DNA dictate 2. The enzyme complex contains five conserved subunits the number and sequence of the amino acids to be of ~60 kDa which carry out ATP-dependent activation incorporated into the resulting oligopeptide. The modular of specific amino acids and share extensive regions of arrangement of peptide synthetases closely parallels the sequence similarity with adenylating enzymes such multienzyme complexes responsible for the biogenesis of as firefly luciferases and acyl-CoA ligases.
    [Show full text]
  • | Hao Wanathi Movie Plena Matuma Wa Mt
    |HAO WANATHI MOVIEUS009943500B2 PLENA MATUMA WA MT (12 ) United States Patent ( 10 ) Patent No. : US 9 ,943 , 500 B2 Page (45 ) Date of Patent: Apr . 17 , 2018 ( 54 ) METHODS OF TREATING TOPICAL A61K 9 /0046 ; A61K 9 / 06 ; A61K 47 /10 ; MICROBIAL INFECTIONS A61K 47 / 14 ; A61K 47 / 44 ; A61K 9 /0048 ; A61K 47/ 06 ; A61L 15 / 46 ; A61L ( 71 ) Applicant: LUODA PHARMA PTY LIMITED , 2300 /404 ; A61L 26 /0066 Caringbah ( AU ) See application file for complete search history . (72 ) Inventor : Stephen Page , Newtown ( AU ) ( 56 ) References Cited (73 ) Assignee : Luoda Pharma Pty Ltd , Caringbah U . S . PATENT DOCUMENTS (AU ) 3 ,873 , 693 A 3 / 1975 Meyers et al . 3 , 920 ,847 A * 11/ 1975 Chalaust .. .. A61K 9 /0014 Subject to any disclaimer, the term of this 514 / 512 ( * ) Notice : 4 ,772 , 470 A * 9 / 1988 Inoue .. .. .. .. .. A61K 9 / 006 patent is extended or adjusted under 35 424 / 435 U . S . C . 154 ( b ) by 0 days . 2005/ 0187199 Al * 8 /2005 Peyman .. .. .. A61K 8 / 36 514 / 154 ( 21) Appl. No .: 14 / 766 , 232 FOREIGN PATENT DOCUMENTS ( 22 ) PCT Filed : FebD . 10 , 2014 EP 0294538 A2 12 / 1988 WO WO - 2003/ 088965 A1 10 / 2003 ( 86 ) PCT No . : PCT/ AU2014 /000101 WO WO - 2006 /081327 A2 8 /2006 $ 371 ( c ) ( 1 ) , WO WO - 2008 /075207 A2 6 / 2008 ( 2 ) Date : Aug. 6 , 2015 OTHER PUBLICATIONS (87 ) PCT Pub . No .: W02014 / 121342 Weese et. al. , Veterinary Microbiology , 2010 , Elsevier, vol. 140 , pp . PCT Pub . Date : Aug . 14 , 2014 418 - 429 . * Brindle , Encyclopedia of Chemical Technology . Polyether antibi otics, Nov . 2013 , Wiley , Abstract and pp .
    [Show full text]
  • By Nicole M. Gaudelli
    MECHANISTIC AND STRUCTURAL STUDIES OF THE THIOESTERASE DOMAIN IN THE TERMINATION MODULE OF THE NOCARDICIN NRPS By Nicole M. Gaudelli A dissertation submitted to The Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, MD 2013 © Nicole M. Gaudelli 2013 All Rights Reserved Abstract The nocardicins are monocyclic -lactam antibiotics produced by the actinomycete Nocardia uniformis subsp., tsuyamanensis ATCC 21806. In 2004 the gene cluster responsible for the biosynthesis of the flagship antibiotic, nocardicin A, was identified. This gene cluster accommodates a pair of non- ribosomal peptide synthetase (NRPS) whose five modules are indispensible for antibiotic production. In accordance with the prevailing co-linearity model of NRPS function, a linear L,L,D,L,L pentapeptide was predicted to be synthesized. Contrary to expectation and precedent, however, a stereodefined series of synthesized potential peptide substrates for the nocardicin thioesterase (NocTE) domain failed to undergo hydrolysis. The stringent discrimination against peptide intermediates was dramatically overcome by prior monocyclic -lactam formation at an L-seryl site to render now facile substrates for C-terminal epimerization and hydrolytic release. It was concluded through biochemical and kinetic experimentation that the TE domain acts as a gatekeeper to hold the assembling peptide on an upstream domain until -lactam formation takes place and then rapidly catalyzes epimerization and hydrolysis to discharge a fully-fledged pentapeptide -lactam harboring nocardicin G, the simplest member of the nocardicin family. An x-ray crystal structure of the TE domain revealed a catalytic center containing the expected Asp, His, Ser triad. Mutational analysis of these catalytic residues along with a proximal His established that the His of the catalytic triad was likely responsible for the epimerization activity rendered by the domain.
    [Show full text]
  • Complete Thesis
    University of Groningen Nonribosomal peptide synthetases Zwahlen, Reto Daniel IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2018 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Zwahlen, R. D. (2018). Nonribosomal peptide synthetases: Engineering, characterization and biotechnological potential. University of Groningen. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). The publication may also be distributed here under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license. More information can be found on the University of Groningen website: https://www.rug.nl/library/open-access/self-archiving-pure/taverne- amendment. Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 04-10-2021 Nonribosomal peptide synthetases: Engineering, characterization and biotechnological potential Academic Thesis, University of Groningen, the Netherlands ISBN: 978-94-034-0674-9 978-94-034-0673-2 (e-book) Printing: Eikon + Cover: Reto D.
    [Show full text]
  • Antimicrobial Resistance in Bacteria
    Cent. Eur. J. Med. • 4(2) • 2009 • 141-155 DOI: 10.2478/s11536-008-0088-9 Central European Journal of Medicine Antimicrobial resistance in bacteria Review Article Katrijn Bockstael*, Arthur Van Aerschot** Laboratory for Medicinal Chemistry, Rega Institute for Medical Research, Katholieke Universiteit Leuven, 3000 Leuven, Belgium Received 9 July 2008; Accepted 17 November 2008 Abstract: The development of antimicrobial resistance by bacteria is inevitable and is considered as a major problem in the treatment of bacterial infections in the hospital and in the community. Despite efforts to develop new therapeutics that interact with new targets, resistance has been reported even to these agents. In this review, an overview is given of the many therapeutic possibilities that exist for treatment of bacterial infections and how bacteria become resistant to these therapeutics. Keywords: Antimicrobial agents • Resistance development • Efflux • Alteration of drug target • Antibacterials © Versita Warsaw and Springer-Verlag Berlin Heidelberg. 1. Introduction 2. Different mechanisms of resistance to antimicrobials The history of humankind can be regarded from a medical point of view as a struggle against infectious 2.1. Intrinsic resistance diseases. Infections were the leading cause of death Bacteria may be inherently resistant to an antimicrobial. th worldwide at the beginning of the 20 century. Since This passive resistance is a consequence of general the discovery of penicillin by Alexander Fleming in adaptive processes that are not necessary linked to a 1929 and the first introduction of the sulpha drugs by given class of antimicrobials. An example of natural Domagk in 1932, the number of new antimicrobials resistance is Pseudomonas aeruginosa, whose low available has increased tremendously between 1940 membrane permeability is likely to be a main reason for and 1960.
    [Show full text]